FDA Requires Strong warnings for Opioid Analgesics, Prescription Opioid Cough Products, and Benzodiazepine Labeling Related to Serious Risks and Death from Combined Use
Action to better inform prescribers and protect patients as part of Agency’s Opioids Action Plan Silver Spring, Maryland–(ENEWSPF)–August 31, 2016. After an … Read more